Načítá se...
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
BACKGROUND: In indolent systemic mastocytosis (ISM), several risk factors of disease progression have been identified. Previous studies, performed with limited patient numbers, have also shown that the clinical course in ISM is stable and comparable to that of cutaneous mastocytosis (CM). The aim of...
Uloženo v:
| Vydáno v: | Allergy |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7115854/ https://ncbi.nlm.nih.gov/pubmed/32108361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.14248 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|